Cargando…
Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review
Interleukin-6 (IL-6) is a proinflammatory cytokine which plays an important role in several regulatory mechanisms of cancer. Moreover, experimental and clinical studies have reported that IL-6 targeted therapies might provide significant benefits for cancer treatment. The purpose of this systematic...
Autores principales: | Uz, Uzdan, Eskiizmir, Görkem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Otorhinolaryngology-Head and Neck Surgery
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904429/ https://www.ncbi.nlm.nih.gov/pubmed/33587847 http://dx.doi.org/10.21053/ceo.2019.00906 |
Ejemplares similares
-
The evaluation of pretreatment neutrophil–lymphocyte ratio and derived neutrophil–lymphocyte ratio in patients with laryngeal neoplasms()
por: Eskiizmir, Gorkem, et al.
Publicado: (2018) -
Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Choudhary, Moaz M., et al.
Publicado: (2016) -
Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma
por: Suzuki, Shinsuke, et al.
Publicado: (2022) -
Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma
por: GAO, JIAN, et al.
Publicado: (2016) -
Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
por: Stanam, Aditya, et al.
Publicado: (2016)